Perfusion Systems Market to 2027- Global Analysis and Forecasts by Type (Microfluidic Perfusion Systems, Small-Mammal Organ Perfusion Systems, Bioreactor Perfusion Systems, gravity or Pressure-Driven Perfusion Systems); Component (Perfusion Pumps, Oxygenators, Herat-Lung Machines, Monitoring Systems, Cannulas and Others) and Geography

Publication Month: Mar 2019 | Report Code: TIPMD00002293 | No. of Pages: 167 | Category: Medical Device | Status: Published

UPDATE AVAILABLE ON-DEMAND
Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Perfusion Systems in healthcare market was valued at US$ 1,044.75 million in 2018 and it is projected to reach US$ 1,442.28 million by 2027; it is expected to grow at a CAGR of 3.8% from 2019 to 2027. Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time (blood flow) per unit tissue mass. During major surgery, perfusion must be maintained and managed by the health professionals involved, rather than left to the body's homeostasis alone. The growth of the Perfusion Systems in healthcare market is attributed to the rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation and rising cell based research activities play vital role in the growth of the perfusion systems market. However, the challenges such as expensive organ transplant surgeries and limited numbers of donors for organ transplant surgeries are likely to impact the growth of the market in the forecast period. On the other hand, technological development from emerging nations hold a significant opportunity for the market growth in the coming years.

 

The Perfusion Systems in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

 

Lucrative Regions for Perfusion Systems in Healthcare Market

Lucrative Regions for Perfusion Systems in Healthcare Market

Get more information on this report :


 

Market Insights

Growing Applications of Perfusion Systems in Healthcare to Drive Perfusion Systems in Healthcare Market Growth

Cardiovascular diseases (CVDs) are the disorders of the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease and other conditions. Some of the major factors which leads to the death and difficulties are use of tobacco, unhealthy diet, and physical inactivity which increases the risk of heart attacks and strokes. CVDs are the leading cause of death across the globe, it affects more people as compared to any other disease. Other than the lifestyle and habit older people are more prone to the cardiovascular diseases. The ageing population commonly show the structural and functional alteration of vessels accumulation through their life. Thus it increases the risk of developing cardiovascular diseases. 

The prevalence of the cardiovascular diseases is increasing across the world. The key factors that lead to the occurrence of cardiovascular diseases among the population. Cardiovascular diseases are major cause of the deaths across the world. As per the American College of Cardiology, it is stated that CVD contributes nearly 800,000deaths in the US, which is approximately to one out every three deaths. The coronary heart disease (CHD) contributes to the majority of CVD deaths which is further followed by stroke and heart failure. Nearly over 90 million Americans get diagnosed with CVD. In addition, it is stated that at a global level cardiovascular diseases contributes around 31% of all deaths and is expected that the cost of the CVD will be approximately to US$ 1,044 billion by 2030.

In Europe, every year cardiovascular disease (CVD) causes 3.9 million deaths and more than 1.8 million deaths in the European Union (EU). The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. CVD is the major reason of the death in men and women in all countries. Therefore, the perfusion systems are required to bypasses the function of the heart and lung during the heart surgery and helps in maintaining the circulation of blood and the oxygen content of the body. Hence, owing to the rising prevalence of cardiovascular diseases in the regions and in various countries, the need of perfusion systems for the treatment of the CVD are likely to increases the market during the forecast period.

The perfusion systems market is also driven by the significant growth of pharmaceutical and biotechnology industry. In the past few years, pharmaceutical and biotechnological industry has been developing at an unusually rapid pace. The rise in the prevalence of the chronic and acute diseases are alarming the need of the medicines, therapeutic, vaccines, antibiotics and others. The technological advancements have assisted the manufacturers with ease in technique to enhance their production. These manufacturers along with their alliance with the contract research organizations (CROs) are confronting to the enormous healthcare challenges through new medicines, therapy forms, progressing digitalization and constantly changing the regulations. In addition, the rise in the geriatric population is leading to rising healthcare conditions. As per the World Health Organization, the global population is increasing by 1.24% per annum leading to rise in number of people in the geriatric class. 

The WHO also suggests that the proportion of people aged 65 to 80 will rise to 28% in 2030, compared to 22% in

2000. Moreover, according to a survey report published by Torreya Economical Model 2017, pharmaceutical industry is 30% larger than its previous estimations till 2017 and contributes to one of the top five industries increasing global economy value. 

Furthermore, the increase in the start-up companies for the pharmaceutical, biopharmaceutical and biotechnology are growing with a good number across the world. These companies are developing innovative drug and therapeutic products and been supported by the respective governments of the countries. Therefore, enormous growth in the production of the medicine and other therapeutic products is shown by the start-up and established players. The production of the medicines and therapeutic products requires the perfusion systems and perfusion systems to produce the raw materials obtained by the biological source. The biotechnology companies are also engaged in the production of the raw materials for the agriculture, food and beverage and other sectors. In contrast to the pharmaceutical industry, biotechnology companies require perfusion systems more. Hence, owing to these factors the market for the perfusion systems is likely to propel in the coming forecast years.

Organ transplantation is a surgical process done when a patient’s organ has stopped functioning completely. The organ transplant is commonly done for the organs such as heart, liver and kidney. However, the rising cases of the chronic diseases are leading to the need of the transplantation for the other organs such as lung, pancreases, cornea, and vascular tissues among others. Organ transplantation is considered as one of the great advanced in the modern medical industry. 

The rise in the chronic diseases that causes damages the functions heart, lung, liver, kidney and other organs are leading to the increasing number of the organ transplantation. The organ transplantation surgeries are rising across the world. For instance, in Spain, approximately 5,260 transplant surgeries were performed, among which nearly 3,200 were kidney transplant and around 1,200 were liver transplant surgeries. The number of heart transplant surgeries were approximately 300 and lung were nearly 360. The public-private partnership in assistance with the transplant coordinators has enormously contributed to the improvement of the organ transplantation. The developing and developed countries have shown good numbers of the organ transplantation surgeries. For instance, developing countries like India and Singapore are emerging as medical tourism destination in the Asia Pacific region. The countries are growing in terms of offering better and advanced medical treatments. 

As per the National Chronic Kidney Disease fact sheet 2017, states that approximately, 30 million people in US are estimated to have chronic kidney diseases. Similarly, according to the National Institute id Diabetes and Digestive and Kidney Diseases states that nearly 661,000 Americans have kidney failure among these nearly, 468,000 patients are taking dialysis, and approximately 193,000 have undergone kidney transplantation. Therefore, the increasing incidences are likely to grow more needs for the kidney transplantation in the coming years. Likewise, it is estimated that the growing numbers of the heart diseases are also responsible to drive the market in coming futures. Thus, the rising need for the organ transplantation is among the key driving factors for the perfusion systems market.

The rise in the chronic diseases, advantages of the applications of biotechnology are growing the extensive cell based research activities. The cell based assays assists in understanding the challenges of biology of the living organisms. The study and research helps to understand the disease processes and its complexity. The cell based assays helps in the understanding the aspects such as cell signaling, proliferation, apoptosis, cellular genetics, neurology, cancer and more. 

The cell based assays are extensively carried out in pharmaceutical, biotechnology industries, research institutes and academics research institutes. The pharmaceutical and biopharmaceutical industries need to efficiently commercialize the drug. Therefore, cell based assays in the pharmaceutical and biotechnology industry are the driving factor for the growth of the perfusion systems. 

The cell based assays are also extensively carried out by the contract research organization for the clinical trial studies and other processes. The chronic diseases such as cancer and other genetic related studies are enforcing for the cell based studies. For instance, Charles River offers services for the human primary cell based assays and according to an article published by the company states that the development in the cell based assays are likely to continue growing in the future. It states that the cell based assays are helpful in the drug discovery as the in vitro to in vivo correlation plays a vital role in the development of a drug. Thus, the increasing cell based research activities are likely to drive the perfusion systems in the forecast period.

 

Type-Based Insights

In terms of type, the Perfusion Systems in healthcare market is segmented into microfluidic perfusion systems, small-mammal organ perfusion systems, bioreactor perfusion systems, gravity or pressure-driven perfusion systems. In 2018, the bioreactors perfusion systems segment held a largest market share of 44.3% of the perfusion systems market, by type.

 

Perfusion Systems in Healthcare Market, by Type – 2018 and 2027

Perfusion Systems in Healthcare Market, by Type – 2018 and 2027

Get more information on this report :


 

Component-Based Insights

Based on component, the Perfusion Systems in healthcare market is segmented into perfusion pumps, oxygenators, heart-lung machines, monitoring systems, cannulas, others. Oxygenators segment is anticipated to grow at a CAGR of 4.4% during the forecast period.

 

Strategic Insights

The Perfusion Systems in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

 

Perfusion Systems in Healthcare Market – by Type

  • Microfluidic Perfusion Systems
  • Small-Mammal Organ Perfusion Systems
  • Bioreactor Perfusion Systems
  • Gravity or Pressure-Driven Perfusion Systems

Perfusion Systems in Healthcare Market – by Component

  • Perfusion Pumps
  • Oxygenators
  • Heart-Lung Machines
  • Monitoring Systems
  • Cannulas
  • Others

Perfusion Systems in Healthcare Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

 

Company Profiles

  • REPLIGEN CORPORATION
  • Merck KGaA
  • Ala Scientific Instruments, Inc.
  • XVIVO Perfusion
  • Medtronic
  • XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
  • Getinge AB
  • TERUMO CORPORATION
  • LivaNova PLC
  • Sartorius AG
  • Harvard Bioscience
  • RAND
  • Sanisure (Sani-Tech West, Inc.)
  • AutoMate Scientific, Inc
  • Jobst Technologies GmbH
  • APD (Advanced Perfusion Diagnostics)
  • Spectrum Medical, Transonic Systems Inc
  • OrganOx
  • ISCHEMAVIEW, INC
  • CESCO BIOENGINEERING CO., LTD

 

1.          INTRODUCTION

1.1      Scope of the Study

1.2      The Insight Partners Research Report Guidance

1.3      market segmentation

1.3.1      Global Perfusion Systems Market – By Type

1.3.2      Global Perfusion Systems Market – By Component

1.3.3      Global Perfusion Systems Market – By Geography

2.          Global Perfusion systems market –  Key takeaways

3.          research Methodology

3.1.1      Coverage

3.1.2      Secondary Research

3.1.3      Primary Research

4.          Global Perfusion systems market –  market landscape

4.1      overview

4.2      pest analysis

4.2.1      North America – PEST Analysis

4.2.2      Europe– PEST Analysis

4.2.3      Asia Pacific– PEST Analysis

4.2.4      Middle East & South Africa– PEST Analysis

4.2.5      South and Central America – PEST Analysis

5.          Global perfusion systems market – Key Market Dynamics

5.1      Key Market Drivers

5.1.1      Rising Prevalence of Cardiovascular Diseases

5.1.2      Significant Growth of Pharmaceutical and Biotechnology Industries

5.1.3      Rising Need for The Organ Transplantation

5.1.4      Rising Cell Based Research Activities

5.2      Key Market Challenges

5.2.1      Expensive Organ Transplant Surgeries

5.2.2      Limited Numbers of Donors for Organ Transplant Surgeries

5.3      Key Market Opportunities

5.3.1      Growth Opportunities in Emerging Regions

5.4      Impact analysis

6.          Perfusion Systems market – Global Analysis

6.1      global Perfusion Systems market Revenue Forecasts and Analysis

6.2      global Perfusion systems market, By Geography - Forecasts and Analysis

6.3      PERFORMANCE OF KEY PLAYERS

6.3.1      Getinge AB

6.3.2      Medtronic

6.4      expert opinions

7.          Global Perfusion Systems Market analysis–  by type

7.1      overview

7.2      Global Perfusion Systems Market BY Type, 2018 & 2027 (%)

7.3      Microfluidic perfusion systems Market

7.3.1      Overview

7.3.2      Global Microfluidic Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

7.4      Small-Mammal Organ perfusion systems market

7.4.1      Overview

7.4.2      Global Small-Mammal Organ Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

7.5      bioreactors perfusion systems maRKET

7.5.1      Overview

7.5.2      Global Bioreactors Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

7.6      gravity or pressure-driven perfusion systems maRKET

7.6.1      Overview

7.6.2      Global Gravity or Pressure-Driven Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

8.           global perfusion systems Market analysis–  by component

8.1      overview

8.2      Global perfusion systems Market, BY component 2018 & 2027 (%)

8.3      perfusion pumps market

8.3.1      Overview

8.3.2      Global Perfusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)

8.4      Oxygenators market

8.4.1      Overview

8.4.2      Global Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)

8.5      heart lung Machine market

8.5.1      Overview

8.5.2      Global Heart-Lung Machine Market Revenue and Forecasts to 2027 (US$ Mn)

8.6      Monitoring Systems market

8.6.1      Overview

8.6.2      Global Monitoring Systems Market Revenue and Forecasts to 2027 (US$ Mn)

8.7      Cannulas market

8.7.1      Overview

8.7.2      Global Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)

8.8      Others market

8.8.1      Overview

8.8.2      Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.          Perfusion SYstems MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS

9.1      north america Perfusion Systems market

9.1.1      Overview

9.1.2      North America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.3      North America Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.4      North America Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.1.5      North America Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)

9.1.6      US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7      US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1    US Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.2    US Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.1.8      Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9      Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9.1    Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.9.2    Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.1.10    Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.11    Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.1.11.1 Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.1.11.2 Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2      Europe Perfusion SYstems market

9.2.1      Overview

9.2.2      Europe Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.3      Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.4      Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2.5      Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)

9.2.6      Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7      Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.1    Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.7.2    Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2.8      UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9      UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.1    UK Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.9.2    UK Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2.10    France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.11    France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.2.11.1 France Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.2.11.2 France Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2.12    Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.13    Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.2.13.1 Spain Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.2.13.2 Spain Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.2.14    Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.15    Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.2.15.1 Italy Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.2.15.2 Italy Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3      ASIA Pacific perfusion systems MARKET

9.3.1      Overview

9.3.2      Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.3      Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.4      Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3.5      Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)

9.3.6      China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7      China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.1    China Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.7.2    China Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3.8      Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9      Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.1    Japan Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.9.2    Japan Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3.10    India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.11    India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.3.11.1 India Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.3.11.2 India Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3.12    Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.13    Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.3.13.1 Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.3.13.2 Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.3.14    South Korea Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.15    South Korea Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                       9.3.15.1 South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                       9.3.15.2 South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.4      Middle East & Africa Perfusion Systems market

9.4.1      Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.2      Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.3      Middle East & Africa Perfusion Systems Market Revenue And Forecasts to 2027, By Component  (US$ Mn)

9.4.4      Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)

9.4.5      UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6      UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.1    UAE Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.6.2    UAE Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.4.7      Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8      Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.1    Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.8.2    Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.4.9      South Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.10    South Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

                        9.4.10.1. South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                        9.4.10.2. South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.5      SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET

9.5.1      Overview

9.5.2      South and Central America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.3      South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.5.4      South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.5.5      South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)

9.5.6      Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7      Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7.1    Brazil Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.5.7.2    Brazil Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

9.5.8      Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.9      Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.9.1    Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.5.9.2    Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

10.        PERFUSION SYSTEMS MARKET –Industry Landscape

10.1    Overview

10.2    Growth Strategies in the perfusion systems Market, 2015-2018

10.3    Organic Developments

10.3.1    Overview

10.4    Organic Growth Strategies in the perfusion systems Market, 2016-2018

10.5    Product Approval

10.5.1    Recent Product Approval by Players in the Perfusion Systems Market, 2015-2018

10.6    Product Launch

10.6.1    Recent Product Launch by Players in the Perfusion Systems Market, 2015-2018

10.7    Others

10.7.1    Others Organic Strategies Made by the Players in the Perfusion Systems Market, 2015-2018

10.8    Inorganic developments

10.8.1    Overview

10.9    inOrganic Growth Strategies in the perfusion systems Market,
2015-2018

10.10  Acquisition

10.10.1  Acquisition Made by the Players in the perfusion systems Market, 2015-2018

10.11  Partnerships

10.11.1  Recent Partnership by Players in the Perfusion Systems Market, 2015-2018

10.12  Collaboration

10.12.1  Collaboration by Players in the Perfusion Systems Market, 2015-2018

10.13  Agreement

10.13.1  Agreement Made by the Players in the Perfusion Systems Market, 2015-2018

11.        Perfusion Systems Market–Key company profiles

11.1    Existing Players

11.1.1    REPLIGEN CORPORATION

11.1.1.1  Key Facts

11.1.1.2  Business Description

11.1.1.3  Financial Overview

11.1.1.4  Product Portfolio

11.1.1.5  SWOT Analysis

11.1.1.6  Key Developments

11.1.2    Merck KGaA

11.1.2.1  Key Facts

11.1.2.2  Business Description

11.1.2.3  Financial Overview

11.1.2.4  Product Portfolio

11.1.2.5  SWOT Analysis

11.1.2.6  Key Developments

11.1.3    ALA Scientific Instruments, Inc.

11.1.3.1  Key Facts

11.1.3.2  Business Description

11.1.3.3  Financial Overview

11.1.3.4  Product Portfolio

11.1.3.5  SWOT Analysis

11.1.3.6  Key Developments

11.1.4    XVIVO Perfusion

11.1.4.1  Key Facts

11.1.4.2  Business Description

11.1.4.3  Financial Information

11.1.4.4  Product Portfolio

11.1.4.5  SWOT Analysis

11.1.4.6  Key Developments


11.1.5    Medtronic

11.1.5.1  Key Facts

11.1.5.2  Business Description

11.1.5.3  Financial Information

11.1.5.4  Product Portfolio

11.1.5.5  SWOT Analysis

11.1.5.6  Key Developments

11.1.6    XENIOS AG (Fresenius Medical Care AG & Co. KGaA)

11.1.6.1  Key Facts

11.1.6.2  Business Description

11.1.6.3  Financial Information

11.1.6.4  Product Portfolio

11.1.6.5  SWOT Analysis

11.1.6.6  Key Developments

11.1.7    TERUMO CORPORATION

11.1.7.1  Key Facts

11.1.7.2  Business Description

11.1.7.3  Financial Overview

11.1.7.4  Product Portfolio

11.1.7.5  SWOT Analysis

11.1.7.6  Key Developments

11.1.8    Getinge AB

11.1.8.1  Key Facts

11.1.8.2  Business Description

11.1.8.3  Financial Overview

11.1.8.4  Product Portfolio

11.1.8.5  SWOT Analysis

11.1.8.6  Key Developments

11.1.9    Harvard Bioscience

11.1.9.1  Key Facts

11.1.9.2  Business Description

11.1.9.3  Financial Overview

11.1.9.4  Product Portfolio

11.1.9.5  SWOT Analysis

11.1.9.6  Key Developments

11.1.10  OrganOx

                       11.1.10.1 Key Facts

                       11.1.10.2 Business Description

                       11.1.10.3 Financial Overview

                       11.1.10.4 Product Portfolio

                       11.1.10.5 SWOT Analysis

                       11.1.10.6 Key Developments

11.2    Emerging Players

11.2.1    Sartorius AG

11.2.1.1  Key Facts

11.2.1.2  Business Description

11.2.1.3  Financial Overview

11.2.1.4  Product Portfolio

11.2.1.5  SWOT Analysis

11.2.1.6  Key Developments

11.2.2    RAND

11.2.2.1  Key Facts

11.2.2.2  Business Description

11.2.2.3  Financial Overview

11.2.2.4  Product Portfolio

11.2.2.5  SWOT Analysis

11.2.2.6  Key Developments

11.2.3    LivaNova PLC

11.2.3.1  Key Facts

11.2.3.2  Business Description

11.2.3.3  Financial Overview

11.2.3.4  Product Portfolio

11.2.3.5  SWOT Analysis

11.2.3.6  Key Developments

11.2.4    Sanisure (Sani-Tech West, Inc.)

11.2.4.1  Key Facts

11.2.4.2  Business Description

11.2.4.3  Financial Overview

11.2.4.4  Product Portfolio

11.2.4.5  SWOT Analysis

11.2.4.6  Key Developments

11.2.5    AutoMate Scientific, Inc.

11.2.5.1  Key Facts

11.2.5.2  Business Description

11.2.5.3  Financial Overview

11.2.5.4  Product Portfolio

11.2.5.5  SWOT Analysis

11.2.5.6  Key Developments

11.2.6    APD (Advanced Perfusion Diagnostics)

11.2.6.1  Key Facts

11.2.6.2  Business Description

11.2.6.3  Financial Overview

11.2.6.4  Product Portfolio

11.2.6.5  SWOT Analysis

11.2.6.6  Key Developments

11.2.7    Spectrum Medical

11.2.7.1  Key Facts

11.2.7.2  Business Description

11.2.7.3  Financial Overview

11.2.7.4  Product Portfolio

11.2.7.5  SWOT Analysis

11.2.7.6  Key Developments

11.2.8    Transonic Systems Inc.

11.2.8.1  Key Facts

11.2.8.2  Business Description

11.2.8.3  Financial Overview

11.2.8.4  Product Portfolio

11.2.8.5  SWOT Analysis

11.2.8.6  Key Developments

11.2.9    ISCHEMAVIEW, INC

11.2.9.1  Key Facts

11.2.9.2  Business Description

11.2.9.3  Financial Overview

11.2.9.4  Product Portfolio

11.2.9.5  SWOT Analysis

11.2.9.6  Key Developments

11.2.10  CESCO BIOENGINEERING CO., LTD.

                       11.2.10.1 Key Facts

                       11.2.10.2 Business Description

                       11.2.10.3 Financial Overview

                       11.2.10.4 Product Portfolio

                       11.2.10.5 SWOT Analysis

                       11.2.10.6 Key Developments

11.2.11  Jobst Technologies GmbH

                       11.2.11.1 Key Facts

                       11.2.11.2 Business Description

                       11.2.11.3 Financial Overview

                       11.2.11.4 Product Portfolio

                       11.2.11.5 SWOT Analysis

                       11.2.11.6 Key Developments

12.        Appendix

12.1    About The Insight Partners

12.2    Glossary of Terms

 

LIST OF TABLES

TABLE 1.           North America Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 2.           North America perfusion systems Market Revenue And Forecasts to 2027, By component  (US$ Mn)

TABLE 3.           US Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 4.           US perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 5.           Canada Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 6.           Canada perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 7.           Mexico Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 8.           Mexico perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 9.           Europe Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 10.         Europe perfusion systems Market Revenue And Forecasts to 2027, By component (US$ Mn)

TABLE 11.         Germany Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 12.         Germany perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 13.         UK Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 14.         UK perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 15.         France Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 16.         France perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 17.         Spain Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 18.         Spain perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 19.         Italy Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 20.         Italy perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 21.         Asia Pacific Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 22.         Asia Pacific perfusion systems Market Revenue And Forecasts to 2027, By component (US$ Mn)

TABLE 23.         China Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 24.         China perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 25.         Japan Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 26.         Japan perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 27.         India Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 28.         India perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 29.         Australia Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 30.         Australia perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 31.         South Korea Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 32.         South Korea perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 33.         Middle East & Africa Perfusion Systems Market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 34.         Middle East & Africa perfusion systems Market Revenue And Forecasts to 2027, By component (US$ Mn)

TABLE 35.         UAE Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 36.         UAE perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 37.         Saudi Arabia Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 38.         Saudi Arabia perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 39.         South Africa Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 40.         South Africa perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 41.         South and Central America Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 42.         South and Central America perfusion systems Market Revenue And Forecasts to 2027,  By component (US$ Mn)

TABLE 43.         Brazil Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 44.         Brazil perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 45.         Argentina Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 46.         Argentina perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)

TABLE 47.         Recent Product approval By Players in the perfusion systems Market, 2015-2018

TABLE 48.         Recent Product Launch By Players in the perfusion systems Market, 2015-2018

TABLE 49.         Others Organic Strategies Made by the Players in the Perfusion Systems Market, 2015-2018

TABLE 50.         Acquisition made by the players in the perfusion systems market, 2015-2018

TABLE 51.         Recent Partnership in the perfusion systems Market, 2015-2018

TABLE 52.         Collaboration in the perfusion systems Market, 2015-2018

TABLE 53.         Agreement made by the players in the Perfusion Systems market, 2015-2018

TABLE 54.         Glossary of Terms, Perfusion systems market

LIST OF FIGURES

FIGURE 1.         Perfusion Systems market Segmentation

FIGURE 2.         perfusion systems Segmentation, by region

FIGURE 3.         Asia Pacific Perfusion systems market, Revenue (US$ Mn), By Geography 2018 & 2027

FIGURE 4.         Global Perfusion systems market By Type, Market Share (%), 2018

FIGURE 5.         Global Perfusion systems market By Component, Market Share (%), 2018

FIGURE 6.         North America PEST Analysis

FIGURE 7.         Europe PEST Analysis

FIGURE 8.         Asia pacific PEST Analysis

FIGURE 9.         Middle East & South Africa PEST Analysis

FIGURE 10.       South and central america PEST Analysis

FIGURE 11.       perfusion systems market impact analysis of driver and Challenges

FIGURE 12.       global Perfusion Systems market – Revenue Forecasts and Analysis –2018- 2027

FIGURE 13.       global Perfusion systems market – by geography Forecasts and Analysis – 2018- 2027

FIGURE 14.       Global Perfusion systems Market, by Type 2018 & 2027 (%)

FIGURE 15.       Global Microfluidic Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 16.       Global Small-Mammal Organ Perfusion Systems Market Revenue and Forecasts to 2027  (US$ Mn)

FIGURE 17.       Global Bioreactors perfusion systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.       Global Gravity Or Pressure-Driven Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.       global perfusion systems Market, by component 2018 & 2027 (%)

FIGURE 20.       global perfusion pumps Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 21.       global Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 22.       global heart-lung machine Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 23.       global monitoring systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 24.       global Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 25.       global others Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 26.       North America Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)

FIGURE 27.       North America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 28.       North America perfusion systems Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 29.       US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 30.       Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 31.       Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 32.       Europe Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)

FIGURE 33.       Europe Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 34.       Europe perfusion systems Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 35.       Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 36.       UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 37.       France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 38.       Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 39.       Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 40.       Asia Pacific Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)

FIGURE 41.       Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 42.       Asia Pacific perfusion systems Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 43.       China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 44.       Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 45.       India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 46.       Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 47.       South Korea Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 48.       Middle East & Africa Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)

FIGURE 49.       Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 50.       Middle East & Africa perfusion systems Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 51.       UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 52.       Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 53.       South Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 54.       South and Central America Perfusion SYstems Market revenue Overview, by Country (2017)  (us $ mn)

FIGURE 55.       South and Central America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 56.       South and Central America perfusion systems Market Revenue And Forecasts to 2027,  By Country (%)

FIGURE 57.       Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 58.       Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 59.       Growth Strategies in the perfusion systems Market, 2015-2018

FIGURE 60.       Organic Growth Strategies in the perfusion systems Market, 2016-2018

FIGURE 61.       Inorganic developments in the perfusion systems Market, 2015-2018

The List of Companies - Perfusion Systems Market

  1. REPLIGEN CORPORATION
  2. Merck KGaA
  3. Ala Scientific Instruments, Inc.
  4. XVIVO Perfusion
  5. Medtronic
  6. XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
  7. TERUMO CORPORATION
  8. Getinge AB
  9. Harvard Bioscience
  10. OrganOx

Emerging Players

  1. Sartorius AG
  2. RAND
  3. LivaNova PLC
  4. Sanisure (Sani-Tech West, Inc.)
  5. AutoMate Scientific, Inc.
  6. APD (Advanced Perfusion Diagnostics)
  7. Spectrum Medical
  8. Transonic Systems Inc
  9. CESCO BIOENGINEERING CO., LTD.
  10. Jobst Technologies GmbH
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the perfusion systems market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global perfusion systems treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPMD00002293
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing